v3.26.3
Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Noncontrolling Interest [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2024 $ 1,997,823   $ 0 $ 63 $ 3,094,182 $ (1,095,227) $ (1,195)
Beginning Balance, Shares at Dec. 31, 2024     0 629,207,115      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2024   $ 21,679          
Stock-based compensation expense 61,048       61,048    
Exercise of stock options 956       956    
Exercise of stock options, Shares       330,413      
Issuance of common stock under employee stock purchase plan, Value 1,650       1,650    
Issuance of common stock under employee stock purchase plan, Shares       174,906      
Issuance of common stock upon vesting of RSUs-net of tax $ (43,471)     $ 1 (43,472)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       9,095,994      
Issuance of restricted stock awards for business acquisition 10,356,096     792,174      
Issuance of common stock for business acquisition [1] $ 250,441     $ 3 250,438    
Issuance of common stock for business acquisition, shares [1]       26,035,603      
Repurchase and retirement of common stock (72,275)     $ (1)   (72,274)  
Repurchase and retirement of common stock, shares       (7,000,000)      
Accretion of redeemable non-controlling interest   1,276          
Accretion of redeemable non-controlling interest (1,276)       (1,276)    
Reclassification of redeemable non-controlling interest   (22,955)          
Foreign currency translation adjustment (15)           (15)
Net income (loss) (17,421)         (17,421)  
Ending Balance at Mar. 31, 2025 2,177,460   $ 0 $ 66 3,363,526 (1,184,922) (1,210)
Ending Balance, Shares at Mar. 31, 2025     0 658,636,205      
Redeemable Non-Controlling Interest, Ending balance at Mar. 31, 2025   0          
Beginning Balance at Dec. 31, 2024 1,997,823   $ 0 $ 63 3,094,182 (1,095,227) (1,195)
Beginning Balance, Shares at Dec. 31, 2024     0 629,207,115      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2024   21,679          
Accretion of redeemable non-controlling interest 1,276            
Foreign currency translation adjustment 121            
Net income (loss) (6,432)            
Ending Balance at Sep. 30, 2025 2,129,822     $ 65 3,449,971 (1,319,140) (1,074)
Ending Balance, Shares at Sep. 30, 2025       647,182,603      
Beginning Balance at Dec. 31, 2024 1,997,823   $ 0 $ 63 3,094,182 (1,095,227) (1,195)
Beginning Balance, Shares at Dec. 31, 2024     0 629,207,115      
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2024   21,679          
Ending Balance at Dec. 31, 2025 1,787,010   $ 0 $ 60 3,483,031 (1,695,057) (1,024)
Ending Balance, Shares at Dec. 31, 2025     0 605,449,050      
Beginning Balance at Mar. 31, 2025 2,177,460   $ 0 $ 66 3,363,526 (1,184,922) (1,210)
Beginning Balance, Shares at Mar. 31, 2025     0 658,636,205      
Redeemable Non-Controlling Interest, Beginning balance at Mar. 31, 2025   0          
Stock-based compensation expense 45,975       45,975    
Exercise of stock options 1,003       1,003    
Exercise of stock options, Shares       360,029      
Issuance of common stock upon vesting of RSUs-net of tax (881)       (881)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       986,566      
Repurchase and retirement of common stock (100,220)     $ (1)   (100,219)  
Repurchase and retirement of common stock, shares       (10,988,327)      
Foreign currency translation adjustment 53           53
Net income (loss) 12,960         12,960  
Ending Balance at Jun. 30, 2025 2,136,350   $ 0 $ 65 3,409,623 (1,272,181) (1,157)
Ending Balance, Shares at Jun. 30, 2025     0 648,994,473      
Redeemable Non-Controlling Interest, Ending balance at Jun. 30, 2025   $ 0          
Stock-based compensation expense 39,193       39,193    
Exercise of stock options 1,671       1,671    
Exercise of stock options, Shares       548,441      
Issuance of common stock under employee stock purchase plan, Value 3,394       3,394    
Issuance of common stock under employee stock purchase plan, Shares       424,270      
Issuance of common stock upon vesting of RSUs-net of tax (3,910)       (3,910)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       1,994,729      
Repurchase and retirement of common stock (44,988)         (44,988)  
Repurchase and retirement of common stock, shares       (4,779,310)      
Accretion of redeemable non-controlling interest 0            
Foreign currency translation adjustment 83           83
Net income (loss) (1,971)         (1,971)  
Ending Balance at Sep. 30, 2025 2,129,822     $ 65 3,449,971 (1,319,140) (1,074)
Ending Balance, Shares at Sep. 30, 2025       647,182,603      
Beginning Balance at Dec. 31, 2025 1,787,010   $ 0 $ 60 3,483,031 (1,695,057) (1,024)
Beginning Balance, Shares at Dec. 31, 2025     0 605,449,050      
Stock-based compensation expense 31,871       31,871    
Exercise of stock options 3,487       3,487    
Exercise of stock options, Shares       1,165,928      
Issuance of common stock under employee stock purchase plan, Value 1,284       1,284    
Issuance of common stock under employee stock purchase plan, Shares       190,081      
Issuance of common stock upon vesting of RSUs-net of tax (17,272)     $ 1 (17,273)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       6,062,951      
Repurchase and retirement of common stock (100,166)     $ (3)   (100,163)  
Repurchase and retirement of common stock, shares       (26,172,456)      
Excise tax on repurchases of common stock (523)         (523)  
Foreign currency translation adjustment 42           42
Net income (loss) 15,417         15,417  
Ending Balance at Mar. 31, 2026 1,721,150   $ 0 $ 58 3,502,400 (1,780,326) (982)
Ending Balance, Shares at Mar. 31, 2026     0 586,695,554      
Beginning Balance at Dec. 31, 2025 1,787,010   $ 0 $ 60 3,483,031 (1,695,057) (1,024)
Beginning Balance, Shares at Dec. 31, 2025     0 605,449,050      
Accretion of redeemable non-controlling interest 0            
Foreign currency translation adjustment 127            
Net income (loss) 66,435            
Ending Balance at Sep. 30, 2026 1,841,885     $ 59 3,571,841 (1,729,118) (897)
Ending Balance, Shares at Sep. 30, 2026       590,525,042      
Beginning Balance at Mar. 31, 2026 1,721,150   $ 0 $ 58 3,502,400 (1,780,326) (982)
Beginning Balance, Shares at Mar. 31, 2026     0 586,695,554      
Stock-based compensation expense 30,387       30,387    
Exercise of stock options 803       803    
Exercise of stock options, Shares       297,269      
Issuance of common stock upon vesting of RSUs-net of tax (689)       (689)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       850,782      
Excise tax on repurchases of common stock 58         58  
Foreign currency translation adjustment 52           52
Net income (loss) 20,787         20,787  
Ending Balance at Jun. 30, 2026 1,772,548   $ 0 $ 58 3,532,901 (1,759,481) (930)
Ending Balance, Shares at Jun. 30, 2026     0 587,843,605      
Stock-based compensation expense 31,536       31,536    
Exercise of stock options 5,021       5,021    
Exercise of stock options, Shares       1,368,234      
Issuance of common stock under employee stock purchase plan, Value 3,054       3,054    
Issuance of common stock under employee stock purchase plan, Shares       696,252      
Issuance of common stock upon vesting of RSUs-net of tax $ (670)     $ 1 (671)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       616,951      
Repurchase and retirement of common stock, shares 0            
Excise tax on repurchases of common stock $ 132         132  
Accretion of redeemable non-controlling interest 0            
Foreign currency translation adjustment 33           33
Net income (loss) 30,231         30,231  
Ending Balance at Sep. 30, 2026 $ 1,841,885     $ 59 $ 3,571,841 $ (1,729,118) $ (897)
Ending Balance, Shares at Sep. 30, 2026       590,525,042      
[1]

(1) Issuance of common stock for business acquisition includes 10,356,096 of restricted shares of common stock subject to re-vesting requirements (see Note 17).

See notes to condensed consolidated financial statements.